Target intelligence / Profile preview

Sodium-glucose cotransporter 1 and Sodium-glucose cotransporter 2 (SGLT1 and SGLT2)

Target
SGLT1 and SGLT2
Molecular classification
Transporter, Membrane protein, Symporter
01

Overview

Sodium-glucose cotransporters are integral membrane proteins that mediate the active transport of glucose across cell membranes by coupling glucose uptake to the inward movement of sodium ions. SGLT1 is mainly expressed in the small intestine where it is essential for absorbing dietary glucose and galactose, and accounts for a small fraction of renal glucose reabsorption. SGLT2 is predominantly found in the renal proximal convoluted tubule and is responsible for reabsorbing the majority of glucose filtered by the kidneys. Inhibition of SGLT2 increases urinary glucose excretion and is the basis for several antidiabetic drugs. Dysfunction or genetic defects in SGLT1 or SGLT2 can lead to specific malabsorption syndromes or glycosuria. The SGLT family is distinct from the facilitative glucose transporter (GLUT) family, which mediates passive glucose movement[1][2][3].

Other names
Sodium-dependent glucose cotransporter 1 (SGLT1)Sodium-dependent glucose cotransporter 2 (SGLT2)SGLT familySLC5A1 (gene for SGLT1)SLC5A2 (gene for SGLT2)sodium-glucose linked transporter
02

Mechanism of action

Inhibition of renal glucose reabsorption by blocking SGLT2 (and SGLT1, by dual inhibitors), lowering blood glucose, promotion of glucosuria

03

Biological functions

Glucose uptakeRenal glucose reabsorptionIntestinal glucose absorptionNutrient absorptionGlucose homeostasis
04

Disease associations

Diabetes mellitus (especially type 2 diabetes)Renal glycosuriaCongenital glucose-galactose malabsorptionObesityCardiovascular disease
05

Safety considerations

Hypoglycemia risk (with SGLT1 inhibition)Urinary tract infectionsGenital infectionsVolume depletion (dehydration)Diabetic ketoacidosisRenal impairment
06

Interacting drugs

Empagliflozin

5 more in the full profile.

07

Biomarkers

Renal glucose in urine (glycosuria)Blood glucose levelsSGLT2 expression in kidney tissue

Beyond the preview

Go deeper on Sodium-glucose cotransporter 1 and Sodium-glucose cotransporter 2 (SGLT1 and SGLT2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-glucose cotransporter 1 and Sodium-glucose cotransporter 2 (SGLT1 and SGLT2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call